Intercure Ltd(INCR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

INCR Intercure Ltd

Market Closed 12-12 16:00:00 EST

1.32

+0.08

+6.15%

盘后1.34

+0.02+1.52%

19:52 EST

High1.45	Low1.27	Vol157.40K
Open1.35	D1 Closing1.24	Amplitude14.48%
Mkt Cap72.18M	Tradable Cap45.73M	Total Shares54.68M
T/O216.28K	T/O Rate0.45%	Tradable Shares34.65M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"INCR","market":"US","secType":"STK","nameCN":"Intercure Ltd","latestPrice":1.32,"timestamp":1765573200000,"preClose":1.2435,"halted":0,"volume":157404,"hourTrading":{"tag":"盘后","latestPrice":1.34,"preClose":1.32,"latestTime":"19:52 EST","volume":1629,"amount":2179.653,"timestamp":1765587136483},"delay":0,"floatShares":34646000,"shares":54681335,"eps":-0.418363,"marketStatus":"Market Closed","change":0.0765,"latestTime":"12-12 16:00:00 EST","open":1.35,"high":1.45,"low":1.27,"amount":216284.7911172,"amplitude":0.144753,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.418363,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.2435,"preHourTrading":{"tag":"盘前","latestPrice":1.35,"preClose":1.26,"latestTime":"09:29 EST","volume":2604,"amount":3645.8715972,"timestamp":1765549799999},"postHourTrading":{"tag":"盘后","latestPrice":1.34,"preClose":1.32,"latestTime":"19:52 EST","volume":1629,"amount":2179.653,"timestamp":1765587136483},"volumeRatio":22.76212871147182,"impliedVol":1.6651,"impliedVolPercentile":0.96},"requestUrl":"/m/hq/s/INCR","defaultTab":"news","newsList":[{"id":"2580333219","title":"InterCure, Cannasoul sign strategic investment, collaboration agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2580333219","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580333219?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:40","pubTimestamp":1762177221,"startTime":"0","endTime":"0","summary":"InterCure (INCR) announced it has entered into a definitive Share Purchase Agreement and a Collaboration Agreement with Cannasoul R&D. The Share Pu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intercure-cannasoul-sign-strategic-investment-collaboration-agreements-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intercure-cannasoul-sign-strategic-investment-collaboration-agreements-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCR","BK4007"],"gpt_icon":0},{"id":"2574413168","title":"Intercure H1 EPS $0.01 Up From $0.00 YoY, Sales $36.292M Miss $66.530M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2574413168","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574413168?lang=en_us&edition=fundamental","pubTime":"2025-10-09 16:32","pubTimestamp":1759998764,"startTime":"0","endTime":"0","summary":"Intercure (NASDAQ:INCR) reported quarterly earnings of $0.01 per share. This is a 700 percent increase over earnings of $0.00 per share from the same period last year.  The company reported quarterly sales of $36.292","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/10/48118122/intercure-h1-eps-0-01-up-from-0-00-yoy-sales-36-292m-miss-66-530m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCR",".IXIC","BK4007"],"gpt_icon":0},{"id":"2573926368","title":"Press Release: InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow","url":"https://stock-news.laohu8.com/highlight/detail?id=2573926368","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573926368?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:02","pubTimestamp":1759928520,"startTime":"0","endTime":"0","summary":"The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive Adjusted EBITDA amidst ongoing recovery in Israel. InterCure is encouraged by recent regulatory momentum in the U.S. and believes that it is well positioned to capitalize on evolving U.S. cannabis rescheduling, especially following its recent signing of an agreement to acquire ISHI. Alexander Rabinovitch, CEO of InterCure, stated: \"In the first half of 2025, InterCure delivered revenues of NIS 130 million, achieving positive Adjusted EBITDA for the eleventh consecutive half year period and generating NIS 12 million in positive operating cash flow. This performance underscores the strength of our vertically integrated business model and our ability to navigate a challenging environment, including the impact of the October 7 attack and the ongoing war in Gaza. We continue to work closely with","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4099","BK4585","ISHI","TM","03160","BK4588","BK4555","BK4604","INCR"],"gpt_icon":0},{"id":"2568298235","title":"Sector Update: Health Care Stocks Mixed Friday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2568298235","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568298235?lang=en_us&edition=fundamental","pubTime":"2025-09-20 01:55","pubTimestamp":1758304533,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index easing 0.01% and the Health Care Select Sector SPDR Fund  adding 0.1%.The iShares Biotechnology ETF  was shedding 0.5%.In corporate news, Amgen's  Uplizna has received a positive opinion from the European Medicines Agency's human medicines committee recommending its approval for adults with active immunoglobulin G4-related disease, a rare autoimmune disorder with no authorized treatments in the EU. Amgen shares rose past 3%.InterCure  shares were down 1.4% after it said Friday it has agreed to buy medical cannabis brand and technology company Botanico, also known as ISHI, in a two-phase deal valued at about 10% of InterCure's outstanding shares on a fully-diluted basis.ARS Pharmaceuticals  shares added nearly 1% after the company said its nasal spray Neffy has received regulatory approval in Japan for the emergency treatment of allergic reactions, including anaphylaxis.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1061106388.HKD","LABU","LU2242652126.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4599","BK4139","LU0889565916.HKD","IE00B2B36J28.USD","LU0320765992.SGD","LU0868494617.USD","BK4534","BK4533","XBI","BK4585","BK4588","LU1983299246.USD","LU2242646821.SGD","IE00BFTCPJ56.SGD","SPRY","XLV","AMGN","LU1571399168.USD","LU0109394709.USD","LU2089984988.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU0058720904.USD","BK4007","BK4566","LU0289739699.SGD","LU2468319806.SGD","SG9999001440.SGD","IE00BJT1NW94.SGD","INCR","LU0122379950.USD","IBB","IE0009355771.USD","LU2112291526.USD","BK4581"],"gpt_icon":0},{"id":"2568265509","title":"InterCure announces acquisition of ISHI for 4.92M ordinary shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2568265509","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568265509?lang=en_us&edition=fundamental","pubTime":"2025-09-19 20:55","pubTimestamp":1758286530,"startTime":"0","endTime":"0","summary":"InterCure (INCR) announced the strategic acquisition of Botanico, also known as ISHI, a premium medical cannabis technology and brand company that ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intercure-announces-acquisition-of-ishi-for-4-92m-ordinary-shares-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intercure-announces-acquisition-of-ishi-for-4-92m-ordinary-shares-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISHI","BK4007","INCR"],"gpt_icon":0},{"id":"2568238263","title":"Press Release: InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands","url":"https://stock-news.laohu8.com/highlight/detail?id=2568238263","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568238263?lang=en_us&edition=fundamental","pubTime":"2025-09-19 20:47","pubTimestamp":1758286020,"startTime":"0","endTime":"0","summary":"Acquisition of leading cannabis company marks major milestone in InterCure's commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologies. Transaction comes as Trump administration confirms it is exploring cannabis rescheduling, creating unprecedented potential opportunities for international operators like InterCure. ISHI brings an exclusive partnership with a top tier indoor facility, sophisticated AI-driven cultivation optimization systems, automated production capabilities, and exclusive partnerships with premium U.S. cannabis brands, including established operators like The Flowery, a leading vertically integrated medical cannabis company. The Flowery operates state-of-the-art cultivation and GMP manufacturing facilities alongside the largest delivery system in Florida's medical market. The Flowery also operates the largest retail chain in NY state and has roadmap to continue its aggressive growth in other U.S. markets. Th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1992135399.USD","BK4007","COO","INCR","CEO","GB00BDT5M118.USD","BK4198","BK4585","LU2211815571.USD","LU2272731600.USD","BK4588","ISHI","LU2272731782.SGD","LU1992135472.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.intercure.co","stockEarnings":[{"period":"1week","weight":-0.0294},{"period":"1month","weight":-0.0294},{"period":"3month","weight":-0.1592},{"period":"6month","weight":-0.1141},{"period":"1year","weight":-0.0133},{"period":"ytd","weight":-0.1698}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.001449},{"month":2,"riseRate":0.5,"avgChangeRate":0.081791},{"month":3,"riseRate":0.5,"avgChangeRate":0.053588},{"month":4,"riseRate":0.75,"avgChangeRate":0.039857},{"month":5,"riseRate":0.5,"avgChangeRate":-0.01186},{"month":6,"riseRate":0,"avgChangeRate":-0.151675},{"month":7,"riseRate":0.5,"avgChangeRate":0.002863},{"month":8,"riseRate":0.75,"avgChangeRate":0.008689},{"month":9,"riseRate":0.25,"avgChangeRate":-0.05775},{"month":10,"riseRate":0.2,"avgChangeRate":-0.119568},{"month":11,"riseRate":0.6,"avgChangeRate":0.016364},{"month":12,"riseRate":0.4,"avgChangeRate":-0.04796}],"exchange":"NASDAQ","name":"Intercure Ltd","nameEN":"Intercure Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Intercure Ltd(INCR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Intercure Ltd(INCR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Intercure Ltd,INCR,Intercure Ltd股票,Intercure Ltd股票老虎,Intercure Ltd股票老虎国际,Intercure Ltd行情,Intercure Ltd股票行情,Intercure Ltd股价,Intercure Ltd股市,Intercure Ltd股票价格,Intercure Ltd股票交易,Intercure Ltd股票购买,Intercure Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Intercure Ltd(INCR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Intercure Ltd(INCR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}